{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-126650","form_type":"8-K","ticker":"NTRB","cik":"0001676047","company_name":"NutriBand Inc.","filed_at":"2025-12-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.119712+00:00","generated_at":"2026-05-16T11:59:57.443588+00:00","sec_items":["7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Nutriband sells 90% stake in Pocono Pharma for $5M to EarthVision Bio; retains 10%","bullets":["Agreement to sell 90% interest in subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio.","Nutriband shareholders will retain 10% stake in EarthVision Bio post-acquisition; closing expected Dec 31, 2025.","Proceeds will fund continued development of AVERSA Fentanyl, an abuse-deterrent opioid patch.","AVERSA Fentanyl has potential annual US sales estimate of $80M to $200M."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-126650","json":"https://secwatch.observer/filing/0001213900-25-126650.json","markdown":"https://secwatch.observer/filing/0001213900-25-126650.md","text":"https://secwatch.observer/filing/0001213900-25-126650.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1676047/000121390025126650/0001213900-25-126650-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1676047/000121390025126650/ea0271298-8k_nutriband.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:59:57.443588+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}